DarioHealth Corp (NASDAQ:DRIO) price on Friday, January 17, rose 6.74% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.69.
A look at the stock’s price movement, the close in the last trading session was $0.65, moving within a range at $0.66 and $0.7449. Turning to its 52-week performance, $2.60 and $0.63 were the 52-week high and 52-week low respectively. Overall, DRIO moved -1.42% over the past month.
DarioHealth Corp’s market cap currently stands at around $26.64 million, with investors looking forward to this quarter’s earnings report slated for in February.
Analysts have a consensus estimate of 7.41M for the company’s revenue for the quarter, with a low and high estimate of 7.4M and 7.42M respectively. The average forecast suggests up to a 104.95% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 26.85M, representing a 31.91% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that DRIO is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend DRIO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
DRIO’s current price about -13.43% and -12.89% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.09, while 7-day volatility ratio is 35.06% and 23.53% in the 30-day chart. Further, DarioHealth Corp (DRIO) has a beta value of 1.41, and an average true range (ATR) of 0.19. Analysts have given the company’s stock an average 52-week price target of $10.75, forecast between a low of $7.5 and high of $14. Looking at the price targets, the low is -986.96% off current price level while to achieve the yearly target high, price needs to move -1928.99%. Nonetheless, investors will most likely welcome a -1457.97% jump to $10.75 which is the analysts’ median price.
If we refocus on DarioHealth Corp (NASDAQ:DRIO), historical trading data shows that trading volumes averaged 2.34 over the past 10 days and 484.39K over the past 3 months. The company’s latest data on shares outstanding shows there are 31.32 million shares.
The 22.38% of DarioHealth Corp’s shares are in the hands of company insiders while institutional holders own 21.01% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.96 million on 2024-12-31, giving us a short ratio of 10.45. The data shows that as of 2024-12-31 short interest in DarioHealth Corp (DRIO) stood at 638.0 of shares outstanding, with shares short rising to 1.91 million registered in 2024-11-29. Current price change has pushed the stock -11.72% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DRIO stock continues to rise going into the next quarter.
